Gregory Reaman, an associate director at the U.S. Food and Drug Administration’s Office of Hematology and Oncology Products and Peter Adamson, chief of the division of clinical pharmacology and therapeutics at the Children’s Hospital of Philadelphia were recently interviewed by Bloomberg, in their recent article, Child Care Survival Imperiled by Lack of New Drugs. The article explores the current treatment and drug options currently made available to children fighting cancer.
For the full Bloomberg article, visit Child Care Survival Imperiled by Lack of New Drugs